Literature DB >> 1413864

Metabolism of pravastatin sodium in isolated rat hepatocytes. I. Glutathione conjugate formation reaction.

S Muramatsu1, K Miyaguchi, H Iwabuchi, Y Matsushita, T Nakamura, T Kinoshita, M Tanaka, H Takahagi.   

Abstract

1. The metabolic fate of pravastatin sodium (sodium (+)-(3R,5R)-3,5-dihydroxy-7-((1'S,2'S,6'S,8'S,8'aR)-6'-hydroxy-2'methyl- 8'-[(S)-2"-methylbutyryloxy]-1',2',6',7',8', 8'a-hexahydro-1'-naphthyl) heptanoate) was studied in isolated rat hepatocytes. 2. Two polar metabolites were isolated and identified as a glutathione conjugate and a dihydrodiol. 3. Both metabolites were formed via an epoxide which has been identified as the 4'a beta,5' beta-epoxide on the decalin moiety. 4. Formation of the glutathione conjugate was enzymic, while the dihydrodiol was formed by non-enzymic hydrolysis of the epoxide accompanied by the intramolecular migration of the double bond.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1413864     DOI: 10.3109/00498259209053111

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  4 in total

1.  Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in rats.

Authors:  M Yamazaki; S Akiyama; R Nishigaki; Y Sugiyama
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

2.  Effects of organic anions and bile acid conjugates on biliary excretion of pravastatin in the rat.

Authors:  S Fukumura; H Takikawa; M Yamanaka
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

3.  Inhibition of in vitro metabolism of simvastatin by itraconazole in humans and prediction of in vivo drug-drug interactions.

Authors:  M Ishigam; M Uchiyama; T Kondo; H Iwabuchi; S Inoue; W Takasaki; T Ikeda; T Komai; K Ito; Y Sugiyama
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

4.  Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys.

Authors:  T Komai; K Kawai; T Tokui; Y Tokui; C Kuroiwa; E Shigehara; M Tanaka
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Apr-Jun       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.